Post by
Minty_33 on Feb 21, 2021 11:29am
How about an update...
On the Macmaster YBG study. A prior NR mentioned that they were ahead of schedule.
From the Company's NR on August 18 2020
"With the expected completion of the third and fourth goals related to tolerability, safety and efficacy studies with both nave and pre-clinical animal models as early as mid-October, our teams are positioning us to be ahead of schedule. Hoping for favorable pre-clinical results, preparations of a Phase 1/2 clinical trial protocol will be commenced immediately and planned to be submitted to Health Authorities during Q4 2020
Now we're past the half way mark of the first quarter of 2021 and not a peep!
Another deadline missed but I think more importantly, zero updates as to why. Why Mr. Gagnon why? Failed communication once again by the President and CEO who duped shareholders into believing that a deal was imminent with the Pepsi's "of this world" in 2019 with the functional drink. If there was better communication with the shareholders, the missed deadlines would be more tolerable.
Comment by
prophetoffacts on Feb 21, 2021 11:50am
This post has been removed in accordance with Community Policy